Participating Faculty: Optimizing Outcomes in the Management of Alzheimer's Disease

The American Journal of Managed Care

The content in this supplement to is based on a roundtable meeting and discussion with a multidisciplinary panel of clinical experts, managed care medical and pharmacy directors, Alzheimer’s disease (AD) advocates, and health economists.

This supplement describes the growing burden of AD, reviews pharmacologic treatment options for AD, and discusses trends and best practices in the management of AD, including the role of combination therapy. It also describes the economic burden of AD and reviews the economic implications of effective management of AD.

Faculty

Alireza Atri, MD, PhD

Associate Director, Clinical Programs

Geriatric Research, Education, and Clinical Center (GRECC)

ENRM VA Bedford Medical Center

Bedford, Massachusetts

Assistant in Neurology

Memory Disorders Unit & Massachusetts Alzheimer’s Disease

Research Center

Department of Neurology

Massachusetts General Hospital

Harvard Medical School

Boston, Massachusetts

Oscar L. Lopez, MD

Professor of Neurology and Psychiatry

University of Pittsburgh

Pittsburgh, Pennsylvania

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Associate Professor

Health Policy

University of the Sciences in Philadelphia

Philadelphia, Pennsylvania

Chief Medical Director

The Access Group

Berkeley Heights, New Jersey

Faculty Disclosures

These faculty report relationships with the following organizations:

Alireza Atri, MD, PhD

Consultant/advisory board:

Forest Laboratories, Inc, Lundbeck, Merz

Grants:

Forest Research Institute

Lecturer:

Lundbeck, Merz

Oscar L. Lopez, MD

Consultant/advisory board:

Johnson & Johnson, Lundbeck

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Lecturer:

Eisai, Forest Laboratories, Inc, Pfizer

The American Journal of ManagedCare

Signed disclosures are on file at the office of , Plainsboro, New Jersey.

This supplement was supported by Forest Laboratories, Inc.

Download PDF: Participating Faculty: Optimizing Outcomes in the Management of Alzheimer's Disease